Pathstone Holdings’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$575K Buy
13,859
+479
+4% +$19.3K ﹤0.01% 1799
2026
Q1
$447K Sell
13,380
-7,751
-37% -$324K ﹤0.01% 1797
2025
Q4
$957K Sell
21,131
-1,778
-8% -$65K ﹤0.01% 1432
2025
Q3
$698K Buy
22,909
+192
+0.8% +$5.9K ﹤0.01% 1601
2025
Q2
$668K Buy
22,717
+51
+0.2% +$1.52K ﹤0.01% 1584
2025
Q1
$792K Sell
22,666
-1,573
-6% -$62.4K ﹤0.01% 1499
2024
Q4
$1.08M Buy
24,239
+3,348
+16% +$150K ﹤0.01% 1333
2024
Q3
$911K Buy
20,891
+4,977
+31% +$188K ﹤0.01% 1417
2024
Q2
$431K Buy
15,914
+4,631
+41% +$134K ﹤0.01% 1772
2024
Q1
$330K Sell
11,283
-334
-3% -$10.1K ﹤0.01% 1887
2023
Q4
$437K Buy
+11,617
New +$427K ﹤0.01% 1596

Other funds holding OMCL

Pathstone Holdings's OMCL Position: Q2 2026 in Review

Pathstone Holdings increased its Omnicell (OMCL) stake by 3.6% in Q2 2026, buying an estimated $19.3K and bringing the position to 13,859 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #1799.

Pathstone Holdings first reported a position in OMCL in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.08M in Q4 2024. 306 funds tracked by Wall St. Rank hold OMCL as of Q2 2026.

  • Pathstone Holdings held 13,859 shares of Omnicell worth $575K as of Q2 2026.
  • Pathstone Holdings bought 479 Omnicell shares in Q2 2026, an estimated $19.3K.
  • Omnicell made up ﹤0.01% of Pathstone Holdings's portfolio in Q2 2026, its #1799 holding.
  • Pathstone Holdings first reported a position in Omnicell in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's Omnicell position peaked at $1.08M in Q4 2024.
  • 306 funds tracked by Wall St. Rank held Omnicell as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.